Jingrong Jean Cui, Director at Turning Point Therapeutics, Inc. (TPTX), sold 11,500 shares at $62.18 ($711K) on 2020-02-13, disclosed to the SEC on 2020-02-14.
Open-market sale of $711k TPTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.83 | 200 | $12K | 1.7% |
| 2 | $60.70 | 2,400 | $146K | 20.5% |
| 3 | $62.18 | 8,800 | $547K | 76.9% |
| 4 | $63.07 | 100 | $6K | 0.9% |
| Total | $61.84 avg | 11,500 | $711K | 100% |
| Filing → |
| TPTX | SELL | 2020-05-21 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-12 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-07 | $5.8M | — | Filing → |